Citations

Showing 10 of 108094 citations.

High-Flow Nasal Cannula on the General Ward for Patients With COVID-19 Enhances ICU and Rapid Response Team Resource Allocation
Zhong, Qiaonan , Chaudhary, Connie W, Stellpflug, Courtney, Wolf, Christine S, Diedrich, Daniel A. , Lehnertz, Andrea, Meyer, Todd J., Oeckler, Richard A. , Stellpflug, Courtney L, De Moraes, Alice Gallo, Chaudhary, Connie W., Lehnertz, Andrea Y., Moraes, Alice Gallo de

Mayo Clinic

Respiratory Care | July 19, 2022 | Volume: 67 | Issue: 12 | Pages: 1606-1608

10.4187/respcare.10087 | PMID 35853708 Get It

The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment
Kamath, Vidyulata , Spychalla, Anthony J., Palta, Priya, Windham, B. Gwen , Griswold, Michael , Jack, Clifford R. , Sharrett, A. Richey, Jack, Clifford R , Senjem, Matthew L. , Chen, Honglei , Mosley, Thomas H. , Knopman, David S. , Gottesman, Rebecca F. , Schneider, Andrea L.C.

Mayo Clinic

Journal of Alzheimer’s Disease | July 19, 2022 | Volume: 89 | Issue: 1 | Pages: 233-245

10.3233/jad-220228 | PMID 35871337 Get It

Background: Olfactory identification (OI) impairment appears early in the course of Alzheimer’s disease dementia (AD), prior to detectable cognitive impairment. However, the neuroanatomical correlates of impaired OI in cognitively normal older adults (CN) and persons with mild cognitive impairment (MCI) are not fully understood. Objective: We examined the neuroanatomic correlates of OI impairment in older adults from the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS). Methods: Our sample included 1,600 older adults without dementia who completed clinical assessment and structural brain imaging from 2011 to 2013. We characterized OI impairment using the 12-item Sniffin’ Sticks odor identification test (score ≤6). We used voxel-based morphometry (VBM) and region of interest (ROI) analyses to examine the neuroanatomic correlates of impaired OI in CN and MCI, after adjusting for potential confounders. Analyses were also separately stratified by race and sex. Results: In CN, OI impairment was associated with smaller amygdala gray matter (GM) volume ( p < 0.05). In MCI, OI impairment was associated with smaller GM volumes of the olfactory cortex, amygdala, entorhinal cortex, hippocampus, and insula (ps < 0.05). Differential associations were observed by sex in MCI; OI impairment was associated with lower insular GM volumes among men but not among women (p-interaction = 0.04). There were no meaningful interactions by race. Conclusion: The brain regions associated with OI impairment in individuals without dementia are specifically those regions known to be the primary targets of AD pathogenic processes. These findings highlight the potential utility of olfactory assessment in the identification and stratification of older adults at risk for AD.
A Quality Improvement Project Aimed at Standardizing the Prescribing of Fluconazole Prophylaxis in a Level IV Neonatal Intensive Care Unit
Smith, Brandi, Rajapakse, Nipunie , Sauer, Hannah E. , Ellsworth, Kevin, Dinnes, Laura , Madigan, Theresa

Mayo Clinic

Pediatric Quality & Safety | July 19, 2022 | Volume: 7 | Issue: 4 | Pages: e579

10.1097/pq9.0000000000000579 | PMID 38585424 Get It

Introduction: Invasive candidiasis has a high morbidity and mortality among premature neonates. Antifungal prophylaxis with fluconazole significantly lowers the risk of invasive fungal infection in this population. We noted the use of fluconazole prophylaxis in our level IV neonatal intensive care unit (NICU) was variable and sought to standardize prescribing of prophylactic fluconazole. Methods: We formed a multidisciplinary team to develop an evidence-based protocol using literature and expert consensus to guide appropriate use of fluconazole prophylaxis in our level IV NICU. After determining baseline fluconazole prophylaxis prescribing before protocol implementation, we used plan-do-study-act (PDSA) cycles to introduce protocolized prescribing and incorporate it into daily practice. A 6-month intervention phase was followed by a 2-year control phase, in which monthly audits were performed to evaluate protocol adherence. Results were displayed in a statistical process control chart. Results: Before protocol implementation, fluconazole prophylaxis prescribing adhered to the protocol in 81% of patients. During the first PDSA cycle, adherence increased significantly to 94.5% (86/91 patients), which further increased to 98.7% (74/75 patients) during the second PDSA cycle and remained at 96% (120/125 patients) during the control phase (P < 0.0001). Conclusions: A multidisciplinary group-designed protocol was successful in standardizing fluconazole prophylaxis prescribing for infants in the level IV NICU. Adherence to protocol was high following implementation and was sustained for the duration of the project. There were no cases of invasive candidiasis noted.
Faculty Opinions recommendation of Loop Diuretics Are Associated with Increased Risk of Hospital-Acquired Acute Kidney Injury in Adult Patients: A Retrospective Study.
Kashani, Kianoush

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.742228336.793594202 Get It

Design and applications of water irradiation devoid RF pulses for ultra-high field biomolecular NMR spectroscopy
Manu, V. S., Olivieri, Cristina , Pavuluri, KowsalyaDevi , Veglia, Gianluigi , Veglia, Gianluigi

Mayo Clinic

Physical Chemistry Chemical Physics | July 19, 2022 | Volume: 24 | Issue: 31 | Pages: 18477-18481

10.1039/d2cp01744j | PMID 35895081 Get It

Water devoid RF pulses designed by an evolutionary algorithm and AI improve solvent suppression and increase the NMR spectra sensitivity.
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma
Karp, Emily E. , O’Byrne, Thomas J., Lu, Lauren , Routman, David M. , Wittich, Michelle A. Neben, Price, Katharine A. , Tasche, Kendall K. , Moore, Eric J. , Abel, Kathryn M. Van , Yin, Linda X , O'Byrne, Thomas Jamie, Lu, Lauren Y, Routman, David M , Lester, Scott C. , Neben Wittich, Michelle A, Moore, Eric J , Van Abel, Kathryn M , Yin, Linda X. , Daniel, J. , Chintakuntlawar, Ashish V. , Price, Daniel L.

Mayo Clinic

The Laryngoscope | July 19, 2022 | Volume: 133 | Issue: 6 | Pages: 1394-1401

10.1002/lary.30307 | PMID 35851669 Get It

ObjectiveFailure to recognize symptoms of non‐human papillomavirus‐associated oropharyngeal squamous cell carcinoma (HPV(−)OPSCC) at presentation can delay diagnosis and treatment. We aim to identify patient factors and provider practice patterns that delay presentation and care in HPV(−)OPSCC.MethodsRetrospective review at a tertiary care center. Patients with HPV(−)OPSCC receiving treatment from 2006 to 2016. Patients were excluded if their date of symptom onset or diagnosis was unknown after thorough review of the electronic medical record or their tissue was not tested for HPV or p16. Clinical data, workup, and care timelines were abstracted. Univariate and multivariable linear regressions were performed to determine associations between patient and provider factors and delays in care.ResultsOf 70 included patients, 52 (74%) were male and mean age was 60.5 (SD = 9.0). Median time to diagnosis was 69 days (IQR = 32–127 days), with a median latency of 30 days (IQR = 12–61 days) from symptom onset to first presentation and 19.5 days (IQR = 4–46 days) from the first presentation to diagnosis. Most patients visited at least 2 providers (n = 52, 74%) before diagnosis. Evaluation by 3 or more providers prior to diagnosis was associated with significant delays in diagnosis of nearly a year (357.7 days, p < 0.001) and being treated or prescribed analgesia prior to diagnosis was significantly associated with delays in diagnosis (p = 0.004) on univariate regression analysis.ConclusionsDelays in care related to evaluations by multiple providers and misdiagnosis prolonged time to diagnosis in HPV(−)OPSCC. Improved patient and provider education is necessary to expedite the diagnosis of HPV(−)OPSCC.Level of Evidence4 Laryngoscope, 133:1394–1401, 2023
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
Tang, Jinyi , Zeng, Cong , Cox, Thomas M, Li, Chaofan , Son, Young Min , Cheon, In Su , Wu, Yue , Taylor, Justin J. , Chakaraborty, Rana, Johnson, Aaron J. , Schiavo, Dante , Utz, James P., Reisenauer, Janani , Midthun, David E. , Mullon, John J., Edell, Eric S. , Alameh, Mohamad‐Gabriel , Borish, Larry , Teague, W. Gerald , Kaplan, Mark H. , Kern, Ryan , Vassallo, Robert , Behl, Supriya, Taylor, Justin J , Chakraborty, Rana , Johnson, Aaron J. , Reisenauer, Janani S , Midthun, David E , Kaplan, Mark H , Weissman, Drew , Kern, R , Hu, Haitao , Vassallo, Robert , Liu, Shan-Lu , Sun, Jie , Tang, J , Li, Chaofan , Behl, Supriya , Chakaraborty, Rana, Liu, Shan-Lu , Sun, Jie

Mayo Clinic

Science Immunology | July 19, 2022 | Volume: 7 | Issue: 76 | Pages: No page available

10.1126/sciimmunol.add4853 | PMID 35857583 Get It

SARS-CoV-2 mRNA vaccination induces robust humoral and cellular immunity in the circulation; however, it is currently unknown whether it elicits effective immune responses in the respiratory tract, particularly against variants of concern (VOCs), including Omicron. We compared the SARS-CoV-2 S–specific total and neutralizing antibody responses, and B and T cell immunity, in the bronchoalveolar lavage fluid (BAL) and blood of COVID-19–vaccinated individuals and hospitalized patients. Vaccinated individuals had significantly lower levels of neutralizing antibody against D614G, Delta (B.1.617.2), and Omicron BA.1.1 in the BAL compared with COVID-19 convalescents despite robust S-specific antibody responses in the blood. Furthermore, mRNA vaccination induced circulating S-specific B and T cell immunity, but in contrast to COVID-19 convalescents, these responses were absent in the BAL of vaccinated individuals. Using a mouse immunization model, we demonstrated that systemic mRNA vaccination alone induced weak respiratory mucosal neutralizing antibody responses, especially against SARS-CoV-2 Omicron BA.1.1 in mice; however, a combination of systemic mRNA vaccination plus mucosal adenovirus-S immunization induced strong neutralizing antibody responses not only against the ancestral virus but also the Omicron BA.1.1 variant. Together, our study supports the contention that the current COVID-19 vaccines are highly effective against severe disease development, likely through recruiting circulating B and T cell responses during reinfection, but offer limited protection against breakthrough infection, especially by the Omicron sublineage. Hence, mucosal booster vaccination is needed to establish robust sterilizing immunity in the respiratory tract against SARS-CoV-2, including infection by the Omicron sublineage and future VOCs.
Fulminant hepatitis following COVID ‐19 vaccination: A case report
Barary, Mohammad , Sharifi‐Razavi, Athena , Sio, Terence T. , Ebrahimpour, Soheil , Baziboroun, Mana , Rakhshani, Nasser , Sio, Terence T , Ebrahimpour, Soheil , Baziboroun, Mana , Barary, Mohammad

Mayo Clinic

Clinical Case Reports | July 19, 2022 | Volume: 10 | Issue: 7 | Pages: No page available

10.1002/ccr3.6066 | PMID 35865787 Get It

Abstract The common side effects of COVID‐19 vaccination were mostly self‐restricted local reactions that quickly resolved. Nevertheless, rare autoimmune hepatitis cases have been reported in some vaccinated with mRNA COVID‐19 vaccines. This article presents a young man who developed fulminant hepatitis a few days after vaccination with the first dose of the AstraZeneca COVID‐19 vaccine. A 35‐year‐old man was admitted to our hospital with generalized weakness, abdominal pain, and jaundice. He received the first dose of the AstraZeneca COVID‐19 vaccine 8 days earlier. He was admitted to the hospital with a chief complaint of abdominal pain. On admission and because of his high D‐dimers, low platelet count, and low Fibrinogen level, vaccine‐induced immune thrombosis thrombocytopenia was suspected, which was ruled out later. Then, after a surge in his liver function tests, decreasing platelet, and abnormal clotting tests, fulminant hepatitis was considered for this patient. Several bacterial, viral, and autoimmune etiologies were then suspected, with all ruled out. Thus, fulminant hepatitis secondary to his AstraZeneca COVID‐19 vaccine was confirmed. Unfortunately, he died 3 days later of disseminated intravascular coagulopathy, after which a liver necropsy was performed, indicating drug/toxin‐induced hepatitis.
An elusive case of malignant optic nerve glioma with a suprasellar mass
Sun, Michelle J., Tran, Ann Q. , Kazim, Michael, Tooley, Andrea A. , Tooley, Andrea A , Dinkin, Marc

Mayo Clinic

Orbit | July 19, 2022 | Volume: 43 | Issue: 2 | Pages: 240-243

10.1080/01676830.2022.2101130 | PMID 35850580 Get It

Doppler-derived haemodynamics performed during admission echocardiography predict in-hospital mortality in cardiac intensive care unit patients
Jentzer, Jacob C. , Tabi, Meir , Anavekar, Nandan S., Oh, Jae K. , TABI, MEIR , Jentzer, Jacob C , Wiley, Brandon M. , Lanspa, Michael J.

Mayo Clinic

European Heart Journal. Acute Cardiovascular Care | July 19, 2022 | Volume: 11 | Issue: 8 | Pages: 640-650

10.1093/ehjacc/zuac084 | PMID 35851395 Get It

Abstract Aims Cardiac point-of-care ultrasound (CV-POCUS) has become a fundamental part for the assessment of patients admitted to cardiac intensive care units (CICU). We sought to refine the practice of CV-POCUS by identifying 2D and Doppler-derived measurements from bedside transthoracic echocardiograms (TTEs) performed in the CICU that are associated with mortality. Methods and results We retrospectively included Mayo Clinic CICU patients admitted from 2007 to 2018 and assessed the TTEs performed within 1 day of CICU admission, including Doppler and 2D measurements of left and right ventricular function. Logistic regression and classification and regression tree (CART) analysis were used to determine the association between TTE variables with in-hospital mortality. A total of 6957 patients were included with a mean age of 68.0 ± 14.9 years (37.0% females). A total of 609 (8.8%) patients died in the hospital. Inpatient deaths group had worse biventricular systolic function [left ventricular ejection fraction (LVEF) 48.2 ± 16.0% vs. 38.7 ± 18.2%, P &lt; 0.0001], higher filling pressures, and lower forward flow. The strongest TTE predictors of hospital mortality were left ventricular outflow tract velocity–time integral [LVOT VTI, adjusted OR 0.912 per 1 cm higher, 95% confidence interval (CI) 0.883–0.942, P &lt; 0.0001] followed by medial mitral E/e′ ratio (adjusted OR 1.024 per 1 unit higher, 95% CI 1.010–1.039, P = 0.0011). Classification and regression tree analysis identified LVOT VTI &lt;16 cm as the most important TTE predictor of mortality. Conclusions Doppler-derived haemodynamic TTE parameters have a strong association with mortality in the CICU, particularly LVOT VTI &lt;16 cm or mitral E/e′ ratio &gt;15. The incorporation of these simplified Doppler-derived haemodynamics into admission CV-POCUS facilitates early risk stratification and strengthens the clinical yield of the ultrasound exam.